Inhibition of HVEM suppresses growth and invasion of mesenchymal glioblastoma
Ryo Tanabe, Bengt Westermark, Carl‐Henrik Heldin, Kohei Miyazono
This study identifies HVEM as a driver of mesenchymal glioblastoma and shows that an anti-HVEM nanobody inhibits tumor growth and invasion.
bioRxiv · Apr 7, 2026 · PreprintCancer Biology